Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business

By Sahil Pandey July 22 (Reuters) - Repligen Corp said on Wednesday it would buy BioLife Solutions in a cash-and-stock deal ...
MarketBeat on MSN

Repligen to buy BioLife Solutions for $1.5 billion, expanding cell therapy reach

Why Medical Products Maker Repligen May Be A Potential Buy Repligen (NASDAQ:RGEN) said it has signed a definitive agreement ...

Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

Fast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s ...
TMCnet

BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc. (NASDAQ: BLFS) to Repligen Corporation for $11.25 per share in cash and 0.1442 shares of Repligen ...
MyNorthwest

Repligen to Acquire Bothell’s BioLife Solutions in $1.5B Deal

Waltham, Massachusetts-based Repligen Corp., a life-sciences company focused on bioprocessing technology leadership, is planning to acquire Bothell-based BioLife Solutions Inc., a developer and ...
Yahoo Finance

Should BioLife Solutions’ 2026 Profitability Guidance and Refocus Require Action From BLFS Investors?

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...